David A. Ramsay
2012
In 2012, David A. Ramsay earned a total compensation of $530.8K as Vice President and Chief Financial Officer at Halozyme Therapeutics, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $40,890 |
|---|---|
| Option Awards | $159,270 |
| Salary | $181,733 |
| Stock Awards | $141,125 |
| Other | $7,811 |
| Total | $530,829 |
Ramsay received $181.7K in salary, accounting for 34% of the total pay in 2012.
Ramsay also received $40.9K in non-equity incentive plan, $159.3K in option awards, $141.1K in stock awards and $7.8K in other compensation.
Rankings
In 2012, David A. Ramsay's compensation ranked 8,580th out of 11,487 executives tracked by ExecPay. In other words, Ramsay earned more than 25.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,580 out of 11,487 | 25th |
Division Manufacturing | 3,115 out of 4,253 | 27th |
Major group Chemicals And Allied Products | 836 out of 1,203 | 31st |
Industry group Drugs | 611 out of 925 | 34th |
Industry Biological Products, Except Diagnostic Substances | 103 out of 165 | 38th |
Source: SEC filing on April 3, 2015.
Ramsay's colleagues
We found five more compensation records of executives who worked with David A. Ramsay at Halozyme Therapeutics in 2012.
2012
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2012
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2012
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2012
James Shaffer
Halozyme Therapeutics
Former Vice President and Chief Commercial Officer
2012
Jean Liu
Halozyme Therapeutics